(Q39940237)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

15 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells (English)

1 reference

15 September 2017

1 reference

Noriyuki Takai

1

1 reference

15 September 2017

Tami Ueda

series ordinal

2

1 reference

15 September 2017

Kaei Nasu

series ordinal

3

1 reference

15 September 2017

Hisashi Narahara

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

13 September 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

111

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

336-343

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

15 September 2017

1 reference

Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitisers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

The CD95(APO-1/Fas) DISC and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Increased surface phosphatidylserine is an early marker of neuronal apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Erucylphosphocholine: pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Modulation of phospholipase D by hexadecylphosphorylcholine: a putative novel mechanism for its antitumoral activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Effects of hexadecylphosphocholine on thrombocytopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Intracellular mediators of erucylphosphocholine-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Bcl-2 mediated inhibition of erucylphosphocholine-induced apoptosis depends on its subcellular localisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Polo-like kinases (Plks) and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Mitotic kinases as regulators of cell division and its checkpoints

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

Disruption of sphingolipid biosynthesis in hepatocyte nodules: selective proliferative stimulus induced by fumonisin B1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.004

10.1016/J.YGYNO.2008.08.004

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference